Award
Delivery Order #SPE2DR26F3HL4
Delivery Order for Meloxicam Tablets Awarded to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$201.21
Ceiling
$201.21
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26F3HL4
NAICS
424210
This contract is a delivery order under an existing Indefinite Delivery Vehicle (IDV) contract awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company. The award specifically covers the procurement of Meloxicam 7.5 mg tablets in substantial quantities, required for federal agency use. This contract ensures the timely and reliable supply of essential medication, which is a critical component of the agency’s pharmaceutical procurement strategy to support public health initiatives. The scope involves the delivery of the specified medication within a very short performance period, highlighting the urgency and precision essential in pharmaceutical logistics. The delivery order follows a competitive or established procurement mechanism under the umbrella of the broader IDV contract, emphasizing the strategic partnership between the agency and AmerisourceBergen. The contract was awarded recently, with the performance and delivery scheduled within a concise timeframe in 2026. This award reinforces the agency's commitment to securing vital pharmaceutical supplies through trusted distributors.
Description
4571166910!MELOXICAM 7.5 MG TABLET 1000S